133 related articles for article (PubMed ID: 37022296)
1. Quality of life in Spanish postmenopausal breast cancer patients with localized disease who finish endocrine treatment: a prospective study.
Arraras JI; Illarramendi JJ; Manterola A; de la Cruz S; Zarandona U; Ibañez B; Salgado E; Visus I; Barrado M; Teiejira L; Martinez MI; Martinez E; Vera R
Menopause; 2023 Jun; 30(6):613-620. PubMed ID: 37022296
[TBL] [Abstract][Full Text] [Related]
2. Quality of life in elderly breast cancer patients with localized disease receiving endocrine treatment: a prospective study.
Arraras JI; Illarramendi JJ; Manterola A; Asin G; Salgado E; Arrondo P; Dominguez MA; Arrazubi V; Martinez E; Viudez A; de la Cruz S; Vera R
Clin Transl Oncol; 2019 Sep; 21(9):1231-1239. PubMed ID: 30712234
[TBL] [Abstract][Full Text] [Related]
3. Quality of life of early-stage breast-cancer patients diagnosed with COVID-19 in the first three waves of the epidemic treated in the Spanish region of Navarre.
Arraras JI; Illarramendi JJ; Manterola A; Cruz S; Zarandona U; Ibañez B; Salgado E; Visus I; Barrado M; Teijeira L; Martinez E; Vera R
Psychooncology; 2023 May; 32(5):730-740. PubMed ID: 36882856
[TBL] [Abstract][Full Text] [Related]
4. Prospective comparison of breast pain in patients participating in a randomized trial of breast-conserving surgery and tamoxifen with or without radiotherapy.
Rayan G; Dawson LA; Bezjak A; Lau A; Fyles AW; Yi QL; Merante P; Vallis KA
Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):154-61. PubMed ID: 12504048
[TBL] [Abstract][Full Text] [Related]
5. Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis.
Ferreira AR; Di Meglio A; Pistilli B; Gbenou AS; El-Mouhebb M; Dauchy S; Charles C; Joly F; Everhard S; Lambertini M; Coutant C; Cottu P; Lerebours F; Petit T; Dalenc F; Rouanet P; Arnaud A; Martin A; Berille J; Ganz PA; Partridge AH; Delaloge S; Michiels S; Andre F; Vaz-Luis I
Ann Oncol; 2019 Nov; 30(11):1784-1795. PubMed ID: 31591636
[TBL] [Abstract][Full Text] [Related]
6. Bridging the age gap in breast cancer: impact of omission of breast cancer surgery in older women with oestrogen receptor-positive early breast cancer on quality-of-life outcomes.
Morgan JL; Shrestha A; Reed MWR; Herbert E; Bradburn M; Walters SJ; Martin C; Collins K; Ward S; Holmes G; Burton M; Lifford K; Edwards A; Ring A; Robinson T; Chater T; Pemberton K; Brennan A; Cheung KL; Todd A; Audisio R; Wright J; Simcock R; Thomson AM; Gosney M; Hatton M; Green T; Revill D; Gath J; Horgan K; Holcombe C; Winter MC; Naik J; Parmeschwar R; Wyld L
Br J Surg; 2021 Apr; 108(3):315-325. PubMed ID: 33760065
[TBL] [Abstract][Full Text] [Related]
7. The EORTC QLQ-ELD14 questionnaire for elderly cancer patients. Validation study for elderly Spanish breast cancer patients.
Arraras JI; Asin G; Illarramendi JJ; Manterola A; Salgado E; Dominguez MA
Rev Esp Geriatr Gerontol; 2019; 54(6):321-328. PubMed ID: 31266659
[TBL] [Abstract][Full Text] [Related]
8. Long term effects of extended adjuvant endocrine therapy on quality of life in breast cancer patients.
Kool M; Fontein DB; Meershoek-Klein Kranenbarg E; Nortier JW; Rutgers EJ; Marang-van de Mheen PJ; van de Velde CJ
Breast; 2015 Jun; 24(3):224-9. PubMed ID: 25704982
[TBL] [Abstract][Full Text] [Related]
9. Assessing the Impact of Organ Failure and Metastases on Quality of Life in Breast Cancer Patients: A Prospective Study Based on Utilizing EORTC QLQ-C30 and EORTC QLQ-BR45 Questionnaires in Romania.
Ionescu Miron AI; Anghel AV; Antone-Iordache IL; Atasiei DI; Anghel CA; Barnonschi AA; Bobolocu AM; Verga C; Șandru F; Lișcu HD
J Pers Med; 2024 Feb; 14(2):. PubMed ID: 38392647
[TBL] [Abstract][Full Text] [Related]
10. Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study.
van Nes JG; Fontein DB; Hille ET; Voskuil DW; van Leeuwen FE; de Haes JC; Putter H; Seynaeve C; Nortier JW; van de Velde CJ
Breast Cancer Res Treat; 2012 Jul; 134(1):267-76. PubMed ID: 22453754
[TBL] [Abstract][Full Text] [Related]
11. Quality of life in the intergroup exemestane study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancer.
Fallowfield LJ; Bliss JM; Porter LS; Price MH; Snowdon CF; Jones SE; Coombes RC; Hall E
J Clin Oncol; 2006 Feb; 24(6):910-7. PubMed ID: 16484701
[TBL] [Abstract][Full Text] [Related]
12. Assessment of quality of life (QoL) in breast cancer patients by using EORTC QLQ-C30 and BR-23 questionnaires: A tertiary care center survey in the western region of Saudi Arabia.
Imran M; Al-Wassia R; Alkhayyat SS; Baig M; Al-Saati BA
PLoS One; 2019; 14(7):e0219093. PubMed ID: 31291302
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive metastatic breast cancer: Patient-reported outcomes in the PEARL study.
Kahan Z; Gil-Gil M; Ruiz-Borrego M; Carrasco E; Ciruelos E; Muñoz M; Bermejo B; Margeli M; Antón A; Casas M; Csöszi T; Murillo L; Morales S; Calvo L; Lang I; Alba E; de la Haba-Rodriguez J; Ramos M; López IÁ; Gal-Yam E; Garcia-Palomo A; Alvarez E; González-Santiago S; Rodríguez CA; Servitja S; Corsaro M; Rodrigálvarez G; Zielinski C; Martín M
Eur J Cancer; 2021 Oct; 156():70-82. PubMed ID: 34425406
[TBL] [Abstract][Full Text] [Related]
14. Aromatase Inhibitors in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer: Profiles of Psychological Symptoms and Quality of Life in Different Patient Clusters.
Borreani C; Alfieri S; Infante G; Miceli R; Mariani P; Bosisio M; Vernieri C; Bianchi GV; Capri G
Oncology; 2021; 99(2):84-95. PubMed ID: 32992318
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life of postmenopausal Chinese women with hormone receptor-positive early breast cancer during treatment with adjuvant aromatase inhibitors: a prospective, multicenter, non-interventional study.
Cao A; Zhang J; Liu X; Wu W; Liu Y; Fan Z; Zhang A; Zhou T; Fu P; Wang S; Ouyang Q; Tang J; Jiang H; Zhang X; Pang D; He J; Shi L; Wang X; Sheng Y; Mao D; Shao Z
Health Qual Life Outcomes; 2016 Mar; 14():51. PubMed ID: 27009092
[TBL] [Abstract][Full Text] [Related]
16. Quality of Life in an e-Cohort of Women Treated by Endocrine Therapy for Early Breast Cancer.
Benoit L; Cambra C; Rouzier R; Cottu P; Rodrigues M; Reyal F; Research Network S; Bonneau C
Clin Breast Cancer; 2022 Apr; 22(3):e352-e361. PubMed ID: 34756686
[TBL] [Abstract][Full Text] [Related]
17. Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial.
Fallowfield L; Cella D; Cuzick J; Francis S; Locker G; Howell A
J Clin Oncol; 2004 Nov; 22(21):4261-71. PubMed ID: 15514369
[TBL] [Abstract][Full Text] [Related]
18. Quality of life in long-term premenopausal early-stage breast cancer survivors from Spain. Effects of surgery and time since surgery.
Ignacio Arraras J; Juan Illarramendi J; de la Cruz S; Asin G; Manterola A; Ibanez B; Salgado E; Cambra K; Zarandona U; Angel Dominguez M; Vera R
J BUON; 2016; 21(5):1090-1098. PubMed ID: 27837609
[TBL] [Abstract][Full Text] [Related]
19. Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.
Roberts KE; Adsett IT; Rickett K; Conroy SM; Chatfield MD; Woodward NE
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013167. PubMed ID: 35005781
[TBL] [Abstract][Full Text] [Related]
20. Quality of life in pre- and postmenopausal patients with early breast cancer: a comprehensive analysis from the prospective MaLife project.
Marschner N; Trarbach T; Rauh J; Meyer D; Müller-Hagen S; Harde J; Dille S; Kruggel L; Jänicke M;
Breast Cancer Res Treat; 2019 Jun; 175(3):701-712. PubMed ID: 30868393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
